Sep
2002

Ongoing NovoSeven((R)) trials.

Erhardtsen E
Intensive Care Med 2002;28(Suppl 2):S248-S256.
NATA Rating :
Review by : Aldouri M
NATA Review
This paper reviews the current trials for the extended use of rFVIIa outside hemophilia patients with inhibitors. These areas include thrombocytopenia, liver disease, trauma, intracerebral hemorrhage, surgery, and anticoagulation.

– M. Aldouri